NIPO trademark

RETSEVMO

RegisteredNIPOWord markClass 5

"RETSEVMO" is a word mark owned by Eli Lilly and Company, filed at the NIPO on October 23, 2020. It is registered and covers class 5 (Pharmaceuticals).

View Eli Lilly and Company portfolioGet this data via the API
Official NIPO record
RETSEVMO
Word mark as filed with the NIPO
Status
Registered
Since March 4, 2021
Filed
October 23, 2020
Registered
March 4, 2021
Expires
October 23, 2030
Application no.
202013447
Registration no.
314326
Office
NIPO
Patentstyret (Norwegian Industrial Property Office)
Mark type
Word mark
1 class
Ownership

Who owns RETSEVMO

The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.

Owner

Eli Lilly and Company

LLY · Indianapolis, United States

8,043 trademarks in the portfolioView company

Representative

Bryn Aarflot AS

Bryn Aarflot AS

Goods and services

What the mark covers

The products and services RETSEVMO is filed for, grouped by Nice class.

  • Farmasøytiske preparater, nemlig farmasøytiske preparater for behandling av alopeci, Alzheimers sykdom, allergisk eksem, autoimmune sykdommer og lidelser, blodsykdommer og -lidelser, ben- og skjelettsykdommer og -lidelser, kreft, kardio-vaskulære sykdommer, sykdommer og forstyrrelser i sentralnervesystemet, cluster-hodepine, koronavirussykdom, Crohns sykdom, demens, dermatologiske sykdommer og forstyrrelser, diabetes, dyslipidemi, endokrine sykdommer og lidelser, fibromyalgi, gastrointestinale sykdommer og lidelser, hodepiner, hjertelammelse og hjertesvikt, betennelser og inflammatoriske sykdommer og lidelser, inflammatorisk tarmsykdom, nyresykdommer og -lidelser, leversykdommer og -lidelser, lupus, psykiske lidelser, metaboliske sykdommer og lidelser, migrene, nevrodegenerative sykdommer og lidelser, nevrologiske lidelser, fedme, osteoartritt, smerte, Parkinsons sykdom, psoriasis, psoriasisartritt, revmatoid artritt, ulcerøs kolitt, vaskulære sykdommer, diagnostiske midler og stoffer for medisinske formål, diagnostiske skanningsmidler (scanning agents) for medisinsk bruk, nemlig diagnostiske skanningsmidler for in vivo bruk; radiofarmasøytiske diagnostiske preparater for medisinsk bruk; radiofarmasøytiske diagnostiske preparater for bruk i diagnostiseringen av nevrodegenerative amyloide sykdomer.

History

What has happened so far

Steps recorded by the NIPO, newest first.

  1. Date of publication of a registered mark
FAQ

About RETSEVMO

Who owns the trademark "RETSEVMO"?

The NIPO trademark "RETSEVMO" (application 202013447) is owned by Eli Lilly and Company.

What is the status of "RETSEVMO"?

Its status at the NIPO is: registered.

When was "RETSEVMO" registered?

It was registered on March 4, 2021 and is due to expire on October 23, 2030.

API

Get this data via the API

Everything on this page comes from the Signa API. Pull RETSEVMO and marks like it into your own product with one request.

  • GET/v1/trademarks/{id}

    The full record: owners, classes, dates and images

  • GET/v1/trademarks/{id}/events

    Every step in the office history

  • GET/v1/proceedings?trademark_id={id}

    Oppositions and cancellations against the mark

Get API keyView docs
GET /v1/trademarks/{id}
ID=tm_019e4bed-de98-7579-9223-239b9e23791b
curl https://api.signa.so/v1/trademarks/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"
Response
{
  "id": "tm_019e4bed-de98-7579-9223-239b9e23791b",
  "object": "trademark",
  "mark_text": "RETSEVMO",
  "status": {
    "primary": "active",
    "stage": "registered"
  },
  "office_code": "NO",
  "application_number": "202013447",
  "filing_date": "2020-10-23",
  "nice_classes": [
    5
  ],
  "owners": [
    {
      "name": "Eli Lilly and Company",
      "entity_id": "ent_019eb749-c2e4-7669-8d85-00996fda299e"
    }
  ]
}